Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Diabetes, Obesity & Metabolism|October 8, 2015
Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trialL A Leiter, H Teoh, O Mosenzon, et al.
Journal of Medicinal Chemistry|January 5, 1996
High-affinity partial agonist imidazo[1,5-a]quinoxaline amides, carbamates, and ureas at the gamma-aminobutyric acid A/benzodiazepine receptor complexE J Jacobsen, R E TenBrink, L S Stelzer, et al.
Gene Therapy|May 8, 2009
Subconjunctival gene delivery of the transcription factor GA-binding protein delays corneal neovascularization in a mouse modelK C Yoon, J A Bae, H J Park, et al.
Plos Genetics|April 5, 2014
Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapyAmy L Stark, Ronald J Hause, Lidija K Gorsic, et al.
Reproduction (Cambridge, England)|September 13, 2003
Differences in embryonic development in sensitive and resistant matings to pregnancy block stimuli in miceH J Chung, J K Pak, B K Kim, et al.
Clinical Pharmacology and Therapeutics|February 20, 2014
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patientsN Pinto, E R Gamazon, N Antao, et al.
Journal of Medicinal Chemistry|April 10, 1999
Piperazine imidazo[1,5-a]quinoxaline ureas as high-affinity GABAA ligands of dual functionalityE J Jacobsen, L S Stelzer, R E TenBrink, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2024
A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancerRegina Cencic, Young K Im, Sai Kiran Naineni, et al.
European Journal of Neurology|July 5, 2014
Higher C-peptide levels are associated with regional cortical thinning in 1093 cognitively normal subjectsC W Yoon, M Kang, H Y Shin, et al.
The Breast Journal|July 20, 2013
Neo-adjuvant capecitabine chemotherapy in women with newly diagnosed locally advanced breast cancer in a resource-poor setting (Nigeria): efficacy and safety in a phase II feasibility studyOlukayode A Arowolo, Uchenna O Njiaju, Temidayo O Ogundiran, et al.
Pageof 9